The National Guideline Clearinghouse (NGC) website, “guideline.gov,” compiles the latest information on medical treatment for use by healthcare organizations, physicians, bulk purchasers, educational institutions, and state and local governments, while also providing guidance on medications and procedures ranging from miniscule to critical. The NGC contains over 20 years of evidence-based clinical practices and medical guidelines, and was first created by the Agency for Healthcare Research and Quality (AHRQ) in partnership with the American Medical Association (AMA). AHRQ created the NGC to keep patients safe, develop and track changes to healthcare, and to help doctors and nurses improve the quality of patient care.
Although the database is accessed daily, the operating costs are about $1.2 million per year and with the Trump Administration looking to execute budget cuts, the Department of Health and Human Services (HHS) has decided to delete the database after July 16, 2018. AHRQ officially halted updates to the database and has stopped creating new guideline summaries as of July 2, 2018. AHRQ is receiving expressions of interest from stakeholders interested in carrying on NGC’s work. It is not clear, however, when or if NGC will be available again. AHRQ’s official announcement is available here: https://www.guideline.gov/home/announcements.
Not only is the future of the database uncertain, but so is the future of the AHRQ. The 2019 fiscal year budget proposed by President Donald Trump would transfer AHRQ’s duties to the National Institutes of Health (NIH), creating a new agency titled the National Institute for Research and Quality. It is unclear whether this new agency will relaunch the database, but at this point there appears to be no plans of another agency or organization taking over or continuing the operation of the NGC. The deletion of the NGC and the elimination of such a vast resource is a major loss to the medical community.